New Delhi, 11 March 2025: Several drugs companies khan tayar ase diabetes therapy toh change kuribo leh ase blockbuster drug Empagliflozin launch kuri kina innovators laka dam laka fraction te.
Kinibo para generics toh market te ahibo olop din pichideh, Boehringer Ingelheim laka patent expiry hoi kina March 11 te, industry sources khan pra TOI ke janai dishey. Generic Empagliflozin laka launch, diabetes, related comorbidities thik kuribo leh chula, heart failure milai kina, promise kuri ase therapy costs toh komti kuribo leh, millions of diabetes ke bishi wala accessible bana boleh aro financial strain toh aram kuribo leh. Kun sai ase drug toh launch hubo leh Mankind Pharma, Torrent, Alkem, Dr Reddy’s aro Lupin khan ase.
Add Comment